Barclays PLC cut its stake in Antero Midstream Co. (NYSE:AM – Free Report) by 14.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,334,762 shares of the pipeline company’s stock after selling 226,746 shares during the period. Barclays PLC owned 0.28% of Antero Midstream worth $20,089,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also made changes to their positions in the company. Advisors Asset Management Inc. increased its holdings in Antero Midstream by 10.5% in the 3rd quarter. Advisors Asset Management Inc. now owns 358,928 shares of the pipeline company’s stock worth $5,402,000 after buying an additional 34,222 shares during the period. Van ECK Associates Corp boosted its stake in Antero Midstream by 98.6% during the 3rd quarter. Van ECK Associates Corp now owns 173,266 shares of the pipeline company’s stock worth $2,564,000 after purchasing an additional 86,001 shares during the last quarter. Westwood Holdings Group Inc. raised its holdings in Antero Midstream by 5.8% in the 2nd quarter. Westwood Holdings Group Inc. now owns 3,359,310 shares of the pipeline company’s stock valued at $49,516,000 after acquiring an additional 184,911 shares during the last quarter. Susquehanna Fundamental Investments LLC grew its holdings in shares of Antero Midstream by 23.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 457,121 shares of the pipeline company’s stock valued at $6,738,000 after purchasing an additional 85,416 shares during the period. Finally, SG Americas Securities LLC acquired a new stake in Antero Midstream during the second quarter worth $559,000. 53.97% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Antero Midstream
In related news, Director Brooks J. Klimley sold 10,000 shares of Antero Midstream stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $14.66, for a total transaction of $146,600.00. Following the sale, the director now directly owns 74,100 shares of the company’s stock, valued at $1,086,306. This trade represents a 11.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.61% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Antero Midstream Stock Up 0.3 %
Shares of Antero Midstream stock opened at $15.11 on Friday. The stock’s fifty day moving average is $15.27 and its 200-day moving average is $14.85. The firm has a market capitalization of $7.27 billion, a PE ratio of 18.65 and a beta of 2.39. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.49. Antero Midstream Co. has a 12-month low of $11.58 and a 12-month high of $16.00.
Antero Midstream Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 6th. Investors of record on Wednesday, October 23rd were paid a $0.225 dividend. This represents a $0.90 annualized dividend and a dividend yield of 5.96%. The ex-dividend date of this dividend was Wednesday, October 23rd. Antero Midstream’s payout ratio is presently 111.11%.
About Antero Midstream
Antero Midstream Corporation owns, operates, and develops midstream energy assets in the Appalachian Basin. It operates in two segments, Gathering and Processing, and Water Handling. The Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collects and processes production from Antero Resources' wells in West Virginia and Ohio.
Further Reading
- Five stocks we like better than Antero Midstream
- Expert Stock Trading Psychology Tips
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to trade using analyst ratings
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Consumer Discretionary Stocks Explained
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Antero Midstream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antero Midstream and related companies with MarketBeat.com's FREE daily email newsletter.